| August 19, 2021 – Vancouver, BC – Alliance Growers Corp. (CSE: ACG; FWB:1LA; OTCPK: ALGWF) (“Alliance Growers” or “the Company) ") negotiates a partnership with a Quebec company with an all-encompassing Hemp License, hemp novelty products and a Cannabis Research License. Management continues to expand its Four Pillars Business Model by adding near revenue “self-financed” business units. The business arrangement with the Quebec company cuts across all Four Pillars and is expected to add significant value for all stakeholders. 1-Products and Services for Cannabis and Hemp Cultivators The Quebec company maintains a unique distribution model to distribute Hemp Seeds and products derived from Hemp Seed Oil. They are currently working on adding new cultivars to Health Canada’s List of Approved Cultivars with its team of seed breeders and international partners. 2-Strategic Alliances with Cannabis and Hemp Cultivators Backed by multiple research agreements, the Quebec company is also licensed to grow, import and export hemp, and is involved in several pilot and commercial hemp grow operations, both in Canada and in Italy. They continue to work with various hemp producers across the country, academic and government researchers and product developers. 3-CBD/THC Infused Products The Quebec company Hemp License includes the ability to process and sell hemp products. Completed products include hemp products formulated to support and boost the gastrointestinal health and boost the immune system. They have several other products under development, subject to research. 4-Research and Technology The Quebec company is licensed to perform research with Cannabis and Hemp. Through their collaboration with a respected University, they have initiated development of a product line designed for gut health. They are also pioneering the cultivation of hemp by bringing it to the forefront to “Do it Yourself” farming. Ongoing research with the National Research Counsel of Canada has inspired certain non-edible products as well. This new line of daily consumer products created by the non-regulated components of the hemp plant proves to be a truly profitable and sustainable vision in this industry. In addition to their all-encompassing Hemp License, the Quebec company also has a “wide scope” Cannabis Research License from Health Canada, which includes Hot and Cold Press Extraction and H20 Solventless Extraction. Commenting on the Quebec partnership, Dennis Petke, President and CEO of Alliance Growers stated, “We are very pleased to have identified this opportunity which rounds out our Four Pillars Business model with the research component. This opportunity immerses Alliance further into the hemp space in Canada which is opening up on multiple levels. Management believes this partnership has realistic potential for near-term revenue in the hemp market on multiple levels. Securing opportunities like this, that are self financed, will benefit all stakeholders.” About Alliance Growers Corp. Alliance Growers is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – 1-Products and Services for Cannabis and Hemp Cultivators through its strategic relationship with Pharmagreen (PHBI), the supply of starter plantlets through a proprietary tissue culture process for the CBD hemp and cannabis industries and the supply of feminized, high percentage CBD hemp seeds, 2-Strategic Alliances with Cannabis and Hemp Cultivators, including the availability of utilizing indoor and outdoor grow facilities, providing cannabis products (Alliance branded pre-rolls) and the potential for export of cannabis product. 3-CBD/THC Infused Products via “self-financed” partnerships including infused spirits and infused health related products; and 4-Research and Technology through strategic relationships with PharamaGreen and B.R.I.M., a company that has expertise in all aspects of cannabis and hemp and others. The Company is in the process of updating its website and company profile with various entities. For further information, please visit the Company’s website at www.alliancegrowers.com or the Company’s profile at www.sedar.com. If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com. For more information contact: Rob Grace Communications Consultant Tel: 778-998-5431 RobDGrace@gmail.com Dennis Petke CEO, President and Director Tel: 778-331-4266 DennisPetke@alliancegrowers.com FORWARD LOOKING INFORMATION This newsletter contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct. Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement. |